Opettajaopiskelijoiden kokemuksia tuesta ja yksilöllisistä järjestelyistä opetusharjoitteluissa

Tiivistelmä. Korkeakouluissa opiskelevien opiskelijoiden joukko on moninainen, ja heillä esiintyy yksilöllisiä tuen tarpeita. Opetusharjoittelut ovat olennainen osa opettajaksi opiskelevien opintoja. Tämän tutkimuksen tavoitteena on kartoittaa opiskelijoiden kokemusten kautta, millä tavalla heitä tuetaan opetusharjoitteluiden aikana, ja miten heidän mielestään opetusharjoitteluiden tukitoimia tulisi kehittää. Tutkimuksen teoreettisessa viitekehyksessä käsitellään korkeakoulujen saavutettavuutta ja sen toteutumista. Korkeakoulujen fyysisen saavutettavuuden koetaan yleisesti toteutuvan hyvin, mutta kehitettävää on erityisesti sosiaalisiin ja psyykkisiin ulottuvuuksiin liittyvissä seikoissa. Teoriaosuudessa käsitellään myös opiskelijoiden yleisimpiä tuen tarpeita, niiden taustatekijöitä sekä korkeakoulujen tarjoamista tukimuodoista. Pro gradu -tutkimuksen aineisto kerättiin kyselylomakkeella luokanopettajaopiskelijoilta sekä erityispedagogiikan opiskelijoilta. Aineisto koostuu 34 vastauksesta, ja opiskelijat ovat Oulun yliopistossa opiskelevia tai jo valmistuneita. Aineisto analysoitiin aineistolähtöisen sisällönanalyysin keinoin. Tutkimuksen tulokset viittaavat siihen, että tukitoimien järjestyminen opetusharjoitteluissa on epäjohdonmukaista. Lisäksi opiskelijat kokevat, että tukitoimista opetusharjoitteluissa ei tarpeeksi aktiivisesti kerrota heille, tuen saaminen on riippuvaista opiskelijan omasta aktiivisuudesta sekä harjoitteluohjaajan suhtautumisesta tuen tarpeeseen. Opiskelijat toivoisivat, että tukitoimista tiedottamista ja opiskelijoiden ohjaamista kehitettäisiin sekä tukea tarjottaisiin aktiivisemmin. Lisäksi asenneilmapiirin toivottaisiin muuttuvan ymmärtäväisemmäksi aikuisten tuen tarpeita kohtaan. Tämän tutkimuksen tuloksissa esiintyy yhteneviä teemoja aiempien tutkimusten kanssa. Erityisesti kehitettävää on tukimuotojen tiedottamisessa. Tämä on noussut myös aiemmissa tutkimuksissa esille koko korkeakoulujen saavutettavuuden suhteen. Opetusharjoitteluiden kehittäminen on ajankohtaista, ja siihen liittyvää tutkimusta olisi perusteltua jatkaa

The interaction of cadmium and selenium in horse kidney cortex in relation to histopathological changes

Creative Commons Licens

Assessing the utilization of the decision to implement a palliative goal for the treatment of cancer patients during the last year of life at Helsinki University Hospital : a historic cohort study

Background: To avoid aggressive treatments at the end-of-life and to provide palliative care (PC), physicians need to terminate futile anti-cancer treatments and define the palliative goal of the treatment in time. This single center study assesses the practices used to make the decision that leads to treatment with a palliative goal, i.e., the PC decision and its effect on anti-cancer treatments at the end of life. Material and methods: Patients with a cancer diagnosis treated in tertiary hospital during 1st January 2013 - 31st December 2014 and deceased by the end of 2014 were identified in the hospital database (N = 2737). Of these patients, 992 were randomly selected for this study. The PC decision was screened from patient records, i.e., termination of cancer-specific treatments and a focus on symptom-centered PC. Results: The PC decision was defined in 82% of the patients during the last year of life (49% >30 days and 33%Peer reviewe

The impact of the duration of the palliative care period on cancer patients with regard to the use of hospital services and the place of death : a retrospective cohort study

Background In order to avoid unnecessary use of hospital services at the end-of-life, palliative care should be initiated early enough in order to have sufficient time to initiate and carry out good quality advance care planning (ACP). This single center study assesses the impact of the PC decision and its timing on the use of hospital services at EOL and the place of death. Methods A randomly chosen cohort of 992 cancer patients treated in a tertiary hospital between Jan 2013 -Dec 2014, who were deceased by the end of 2014, were selected from the total number of 2737 identified from the hospital database. The PC decision (the decision to terminate life-prolonging anticancer treatments and focus on symptom centered palliative care) and use of PC unit services were studied in relation to emergency department (ED) visits, hospital inpatient days and place of death. Results A PC decision was defined for 82% of the patients and 37% visited a PC unit. The earlier the PC decision was made, the more often patients had an appointment at the PC unit (> 180 days prior to death 72% and <14 days 10%). The number of ED visits and inpatient days were highest for patients with no PC decision and lowest for patients with both a PC decision and an PC unit appointment (60 days before death ED visits 1.3 vs 0.8 and inpatient days 9.9 vs 2.9 respectively, p <0.01). Patients with no PC decision died more often in secondary/tertiary hospitals (28% vs. 19% with a PC decision, and 6% with a decision and an appointment to a PC unit). Conclusions The PC decision to initiate a palliative goal for the treatment had a distinct impact on the use of hospital services at the EOL. Contact with a PC unit further increased the likelihood of EOL care at primary care.Peer reviewe

Palliatiivisen lääketieteen opetus lääketieteen kandidaattien arvioimana

Lähtökohdat Palliatiivinen lääketiede on lääkärin ydinosaamista, mutta alan professuuri ja opetussuunnitelma ovat vain Helsingin ja Tampereen yliopistoissa. Menetelmät Lukuvuonna 2018–2019 kaikissa Suomen lääketieteellisissä tiedekunnissa kysyttiin kysely­lomakkeella valmistuvien kandidaattien näkemyksiä palliatiivisen lääketieteen opetuksesta. Tulokset Vastaajista (n = 502) lähes kaikki (98 %) pitivät palliatiivisen lääketieteen opetusta hyödyllisenä. Opetus oli kattanut parhaiten kivun hoidon, heikoimmin psyykkiset oireet ja psykososiaalisen tuen. Lisäopetusta olisi kaivattu eniten hoitolinjauksista ja psykososiaalisista seikoista. Tampereen ja Helsingin yliopistojen vastaajat kokivat opetuksen kattaneen paremmin lähes kaikki osa-alueet verrattuna muiden yliopistojen vastaajiin. Helsingin ja Tampereen opiskelijoista 80–90 % kertoi kohdanneensa saattohoitopotilaan opetuksessa, kun muista näin arvioi noin kolmannes. Avoimissa vastauksissa korostui tarve opetukseen ennen ensimmäisiä lääkärin työtehtäviä. Päätelmät Kokemukset palliatiivisen lääketieteen opetuksesta vaihtelivat yliopistojen välillä. Valtakunnallisen palliatiivisen lääketieteen opetussuunnitelman käyttöönotto on tarpeen.</p

Palliatiivisen lääketieteen opetus lääketieteen kandidaattien arvioimana

Vertaisarvioitu. English summary.Lähtökohdat : Palliatiivinen lääketiede on lääkärin ydinosaamista, mutta alan professuuri ja opetussuunnitelma ovat vain Helsingin ja Tampereen yliopistoissa. Menetelmät : Lukuvuonna 2018–2019 kaikissa Suomen lääketieteellisissä tiedekunnissa kysyttiin kysely¬lomakkeella valmistuvien kandidaattien näkemyksiä palliatiivisen lääketieteen opetuksesta. Tulokset : Vastaajista (n = 502) lähes kaikki (98 %) pitivät palliatiivisen lääketieteen opetusta hyödyllisenä. Opetus oli kattanut parhaiten kivun hoidon, heikoimmin psyykkiset oireet ja psykososiaalisen tuen. Lisäopetusta olisi kaivattu eniten hoitolinjauksista ja psykososiaalisista seikoista. Tampereen ja Helsingin yliopistojen vastaajat kokivat opetuksen kattaneen paremmin lähes kaikki osa-alueet verrattuna muiden yliopistojen vastaajiin. Helsingin ja Tampereen opiskelijoista 80–90 % kertoi kohdanneensa saattohoitopotilaan opetuksessa, kun muista näin arvioi noin kolmannes. Avoimissa vastauksissa korostui tarve opetukseen ennen ensimmäisiä lääkärin työtehtäviä. Päätelmät : Kokemukset palliatiivisen lääketieteen opetuksesta vaihtelivat yliopistojen välillä. Valtakunnallisen palliatiivisen lääketieteen opetussuunnitelman käyttöönotto on tarpeen.Peer reviewe

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation

Heart failure (HF) is a major and growing public health problem in the United States. Approximately 5 million patients in this country have HF, and over 550,000 patients are diagnosed with HF for the first time each year. The disorder is the primary reason for 12 to 15 million office visits and 6.5 million hospital days each year. From 1990 to 1999, the annual number of hospitalizations has increased from approximately 810,000 to over 1 million for HF as a primary diagnosis and from 2.4 to 3.6 million for HF as a primary or secondary diagnosis. In 2001, nearly 53 000 patients died of HF as a primary cause. The number of HF deaths has increased steadily despite advances in treatment, in part because of increasing numbers of patients with HF due to better treatment and “salvage” of patients with acute myocardial infarctions (MIs) earlier in life. Heart failure is primarily a condition of the elderly, and thus the widely recognized “aging of the population” also contributes to the increasing incidence of HF. The incidence of HF approaches 10 per 1000 population after age 65, and approximately 80% of patients hospitalized with HF are more than 65 years old. Heart failure is the most common Medicare diagnosis-related group (i.e., hospital discharge diagnosis), and more Medicare dollars are spent for the diagnosis and treatment of HF than for any other diagnosis. The total estimated direct and indirect costs for HF in 2005 were approximately $27.9 billion. In the United States, approximately$2.9 billion annually is spent on drugs for the treatment of HF

The impact of the duration of the palliative care period on cancer patients with regard to the use of hospital services and the place of death: a retrospective cohort study

Background: In order to avoid unnecessary use of hospital services at the end-of-life, palliative care should be initiated early enough in order to have sufficient time to initiate and carry out good quality advance care planning (ACP). This single center study assesses the impact of the PC decision and its timing on the use of hospital services at EOL and the place of death. Methods: A randomly chosen cohort of 992 cancer patients treated in a tertiary hospital between Jan 2013 -Dec 2014, who were deceased by the end of 2014, were selected from the total number of 2737 identified from the hospital database. The PC decision (the decision to terminate life-prolonging anticancer treatments and focus on symptom centered palliative care) and use of PC unit services were studied in relation to emergency department (ED) visits, hospital inpatient days and place of death. Results: A PC decision was defined for 82% of the patients and 37% visited a PC unit. The earlier the PC decision was made, the more often patients had an appointment at the PC unit (> 180 days prior to death 72% and Conclusions: The PC decision to initiate a palliative goal for the treatment had a distinct impact on the use of hospital services at the EOL. Contact with a PC unit further increased the likelihood of EOL care at primary care.</div

Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer

<p>Abstract</p> <p>Background</p> <p>The human epidermal growth factor receptor 2 (HER2) and p53 pathways may be involved in chemotherapy sensitivity and/or resistance. We explore the value of HER2 and p53 status to foretell docetaxel sensitivity in advanced breast cancer.</p> <p>Methods</p> <p>HER2 and p53 expression was analysed in 36 (median age 55 yrs; range 37-87) metastatic breast cancer patients receiving docetaxel-based first-line chemotherapy. HER2 was determined by immunohistochemistry (IHC) and fluorescence <it>in situ </it>hybridization (FISH), p53 was tested by IHC. We correlate the expression of study parameters with pathologic parameters, RECIST response and survival. The standard cut-off value of 2 was used to determine HER2 overexpression while p53 mean expression level was used to divide low/high expressors tumors.</p> <p>Results</p> <p>Median time to progression and overall survival were 9 (range 2 - 54) and 20 (range 3 - 101) months. Overall response rate was 41.6%. Nine cases showed HER2 overexpression. HER2 was more frequently overexpressed in less differentiated (<it>p </it>= 0.05) and higher stage (<it>p </it>= 0.003) disease. Mean FISH-HER2 values were significantly higher in responder than in non-responder pts (8.53 ± 10.21 vs 2.50 ± 4.12, <it>p </it>= 0.027). Moreover, HER2 overexpression correlates with treatment response at cross-tabulation analysis (<it>p </it>= 0.046). p53 expression was only associated with higher stage disease (<it>p </it>= 0.02) but lack of any significant association with HER status or docetaxel response. No significant relation with survival was observed for any parameter.</p> <p>Conclusion</p> <p>Our data seem to indicate that FISH-determined HER2 status but not p53 is associated with docetaxel sensitivity in metastatic breast cancer.</p

Prevalence of age-related hearing loss in Europe: a review

Populations are becoming progressively older thus presenting symptoms of diminished organ function due to degenerative processes. These may be physiological or caused by additional factors damaging the organ. Presbyacusis refers to the physiological age-related changes of the peripheral and central auditory system leading to hearing impairment and difficulty understanding spoken language. In contrast to epidemiological data of other continents, the prevalence of age-related hearing loss (ARHL) in Europe is not well defined, due in part to the use of different classification systems. We performed a systematic literature review with the aim of gaining a picture of the prevalence of ARHL in Europe. The review included only population and epidemiological studies in English since 1970 with samples in European countries with subjects aged 60 years and above. Nineteen studies met our selection criteria and additional five studies reported self-reported hearing impairment. When these data were crudely averaged and interpolated, roughly 30% of men and 20% of women in Europe were found to have a hearing loss of 30 dB HL or more by age 70 years, and 55% of men and 45% of women by age 80 years. Apparent problems in comparing the available data were the heterogeneity of measures and cut-offs for grades of hearing impairment. Our systematic review of epidemiological data revealed more information gaps than information that would allow gaining a meaningful picture of prevalence of ARHL. The need for standardized procedures when collecting and reporting epidemiological data on hearing loss has become evident. Development of hearing loss over time in conjunction with the increase in life expectancy is a major factor determining strategies of detection and correction of ARHL. Thus, we recommend using the WHO classification of hearing loss strictly and including standard audiometric measures in population-based health surveys